Appendicular Skeletal Muscle Mass Study
- Conditions
- SarcopeniaPublic Health
- Interventions
- Radiation: Dual energy X-ray absorptiometry
- Registration Number
- NCT04584944
- Lead Sponsor
- Henry Dunant Hospital Center
- Brief Summary
There is a lot of discussion concerning the normal cut-off points of skeletal mass among different populations worldwide. Genetic and environmental differences most probably lead to different measurements. Defining muscle mass in healthy young adults in Greece will provide information that can be used to determine normal ranges of muscle mass of both sexes and consequently define sarcopenia.
The aim of the study is to define appendicular skeletal muscle mass reference measurements in healthy young adults in Greece. These values can be used to determine sarcopenia cut-offs according to recommendations.
- Detailed Description
Introduction
The reduction of muscle mass in humans is obvious after the age of fifty, with a reduction rate of 3-8% every ten years. The rate of loss accelerates with chronic diseases, sedentary lifestyle, low physical activity, nutritional, environmental and socioeconomic factors .
Sarcopenia has been officially recognized as a disease according to World Health Organization. European Working Group on Sarcopenia in Older People 2 has revised the definition and diagnostic criteria of sarcopenia aiming to encourage more research in the field. In Greece, there are no reference values for muscle strength and muscle mass. Defining these values will permit the investigators to provide a tool that will help to establish country - specific measurements of sarcopenia in Greek population.
Study population-Methods
The study site will be the Outpatient Geriatric Assessment Unit and the Radiology Department of Henry Dunant Hospital Centre, in Athens-Greece.
The study population will be healthy adults that meet the inclusion criteria. The recruitment will be performed using the snowball sampling technique (for instance, through printed material, the marketing department of the hospital, social media, advertising banners, etc.). Stratified random sampling technique will be used to achieve a representative sample size.
Evaluation of the appendicular muscle mass of the limbs will be performed by Dual-Energy X-ray Absorptiometry, using a QDR-4500 A fan Beam densitometer (Hologic, Inc., Bedford, MA). Hologic Discovery W configured with software version 12.1 (Hologic, Bedford, MA).
Body composition analysis will be evaluated with TANITA Body Composition Analyzer device,model BC-418MA. Analysis concerns calculation of body consistency (body fat mass, lean mass water and predicted muscle mass) using Bioelectric Impedance Analysis. Bioelectric Impedance Analysis measures the body composition using a constant power source (high frequency current 50kHz, 90 μA).
Muscle mass will also be measured by ultrasound -U/S. U/S determines the thickness and transverse incisions of a superficial muscle group. It can measure basic parameters such as muscle volume and spectrum length through the B-Mode imaging with Linear 7-12MHz frequency heads that can reliably determine the thickness and transverse incisions of the superficial muscular Groups.
Statistical analysis
It will be performed using the Statistical Package for the Social Sciences -SPSS Version 26.0 (IBM), and R Version 3.6.2.
Descriptive statistics will be presented in percentage proportions, mean values and Standard Deviations (SD) of the variables. In addition, Z-score will be calculated (e.g. Dual-energy X-ray absorptiometry , Bone Mineral density, Dual-energy X-ray absorptiometry % fat, etc.) and T-score ± 2 standard deviations.
Chi-square - χ2 tests or non-parametric tests will be produced to compare qualitative variables. T-test, Analysis of Variance- ANOVA and non-parametric tests will be used in the statistical analysis of quantitative variables within the categories of qualitative variables.
Approval
The protocol has been approved by the Scientific Committee of the Henry Dunant Hospital Centre, in Athens -Greece, and is in accordance with the Code of Ethics of the World Organization for Medical Sciences (CIOMS) as formulated in the Helsinki Declaration on Biological Research.
Informed consent
All participants will be informed in written for the purpose of the research, and the way their personal data are processed (name, address, telephone, e-mail), under the provisions of 2016/679 according to the General Data Protection Regulation (GDPR).
The consent form will describe the legal and transparent way of processing their data, stating the specific purpose for data collection, as well as information about storage of their data. It will also contain a written description of the rights of the participants concerning their data and their ability to revoke consent for the processing of their data. The processing, transfer and storage of data, will also be described, as well as who will have access to their data, and how long the data will be stored for.
Finally, all participants will sign the written informed consent and confidentiality form.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 500
- Healthy Greek young adults (20 - 44 years old), with Caucasian characteristics.
- Able to read and write in Greek language.
- Chronic diseases, such as, heart diseases, type II diabetes mellitus and autoimmune diseases.
- Hyperthyroidism or hypothyroidism (persons with normal thyroid function for six months are included).
- Malignancies.
- Seizures of epilepsy, neurodegenerative diseases.
- Asthma and/or chronic respiratory pulmonary disease-Chronic Obstructive Pulmonary Disease.
- Metal prefixes.
- Pacemaker.
- Systematic medication intake (such as hypolipemic drugs, antihypertensive drugs, antidepressants, glucocorticoids and any other hormonal treatment).
- Protein formulations and anabolic intake.
- Hormone intake (testosterone, estrogen, contraceptive, growth hormone, dehydroepiandrosterone.
- Professional athletes and people with intense physical activity, intensive exercise with weights, long-distance runners (Marathons).
- Substance use or abuse (cocaine, heroin, amphetamines).
- Pregnancy.
- History of hospitalization in Intensive Care Unit
- History of serious injury
- Considerable body weight alterations during the previous year (increase or decrease)
- History of Bariatric surgery
- Any dietary restriction due to disease (sprue), choice (vegan), or eating disorder (anorexia nervosa).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Healthy adult women Dual energy X-ray absorptiometry Healthy young women, 20- 44 years old Healthy adult men Dual energy X-ray absorptiometry Healthy young men, 20- 44 years old
- Primary Outcome Measures
Name Time Method Appendicular skeletal muscle mass reference measurements of healthy young adults in Greece 01/06/2022 Measurements of appendicular skeletal muscle mass of healthy young adults in Greece that will be used to define sarcopenia in older adults and as normative values.
Define reference measurements for muscle performance 01/06/2022 Reference measurements for walking speed
Define reference measurements for muscle strength. 01/06/2022 Reference measurements for hand grip
- Secondary Outcome Measures
Name Time Method Correlation of muscle mass with demographic characteristics 01/06/2022 Investigate correlation of muscle mass with demographic characteristics of the studied population
Correlation of bone mass with demographic characteristics 01/06/2022 Investigate correlation of bone mass with demographic characteristics of the studied population.
Correlation of adherence to Mediterranean diet with muscle mass 01/06/2022 Investigate potential correlation of adherence to Mediterranean diet with muscle mass.
Correlations between the different tools used to measure muscle mass 01/06/2022 Investigate accuracy and potential differences between the different techniques used to measure muscle mass.
Correlation of fat mass with demographic characteristics 01/06/2022 Investigate correlation of fat mass with demographic characteristics of the studied population.
Trial Locations
- Locations (1)
Henry Dunant Hospital Center
🇬🇷Athens, Greece